Antiphospholipid Syndrome Clinical Trials in Shanghai, Shanghai Municipality
2 recruitingShanghai, Shanghai Municipality, China
Showing 1–2 of 2 trials
Recruiting
Phase 2
Effect of Belimumab on Antibody Titers in Primary APS Patients
Antiphospholipid Syndrome (APS)
Ruijin Hospital20 enrolled1 locationNCT06747312
Recruiting
Not Applicable
An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
Systemic Lupus ErythematosusInflammatory MyopathyAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd.6 enrolled1 locationNCT06379646